Trials / Completed
CompletedNCT00604409
Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
Phase I Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Fox Chase Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.
Detailed description
Patients with adequate liver function and performance status in whom liver-directed therapy and capecitabine would be appropriate are eligible for this clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | SIRT | Undergo SIRT |
| DRUG | capecitabine | Given PO |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2014-06-01
- Completion
- 2015-01-01
- First posted
- 2008-01-30
- Last updated
- 2015-09-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00604409. Inclusion in this directory is not an endorsement.